Pharmacologic treatment of poststroke depression: A systematic review of the literature

Topics in Stroke Rehabilitation

Volumn 10, Issue 1, 2003, Pages 79-92

  Van de Meent, H ^a   Geurts, A C H ^b   Van Limbeek, J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Antidepressive agents; Depression; Drug therapy; Stroke; Treatment

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; METHYLPHENIDATE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; EYE DISEASE; FATIGUE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HEART ATRIUM FLUTTER; HUMAN; MEDICAL LITERATURE; MICTURITION DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SEDATION; SIDE EFFECT; STROKE; TACHYCARDIA; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; DEPRESSIVE DISORDER; HUMANS;

EID: 0038662891     PISSN: 10749357     EISSN: None     Source Type: Journal    
DOI: 10.1310/B51G-29MP-25HQ-ARNH     Document Type: Review

References (66)

1. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry. 1995;166:320-327.
2. Robinson RG, Starr LB, Kubos KL, Price TR. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke. 1983;14:736-741.
3. Robinson RG, Starr LB, Price TR. A two year longitudinal study of mood disorders following stroke. Prevalence and duration at six months follow-up. Br J Psychiatry. 1984;144:256-262.
4. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993;24:976-982.
5. Robinson RG, Bolla-Wilson K, Kaplan E, Lipsey JR, Price TR. Depression influences intellectual impairment in stroke patients. Br J Psychiatry. 1986;148:541-547.
6. Teasell RW, Merskey H, Deshpande S. Antidepressants in rehabilitation. Phys Med Rehabil Clin N Am. 1999;10:237-253, vii.
7. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. Br J Psychiatry. 1987;151:52-56.
8. Sinyor D. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke. 1986;17:1102-1107.
9. van de Weg FB, Kuik DJ, Lankhorst GJ. Poststroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999;13:268-272.
10. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol. 1990;47:785-789.
11. Clark MS, Smith DS. The effects of depression and abnormal illness behavior on outcome following rehabilitation from stroke. Clin Rehabil. 1998;12:73-80.
12. Cushman LA. Secondary neuropsychiatric complications in stroke: implications for acute care. Arch Phys Med Rehabil. 1988;69:877-879.
13. Toedter LJ, Schall RR, Reese CA, Hyland DT, Berk SN, Dunn DS. Psychological measures: reliability in the assessment of stroke patients. Arch Phys Med Rehabil. 1995;76:719-725.
14. Gordon WA, Hibbard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil. 1997;78:658-663.
15. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235-1241.
16. Kneebone DE II. Psychological management of post-stroke depression. Br J Clin Psychol. 2000;39:53-65.
17. Goodnick PJ, Hernandez M. Treatment of depression in comorbid medical illness. Expert Opin Pharmacother. 2000;1:1367-1384.
18. Cole MG, Elie LM, McCusker J, Bellavance F, Mansour A. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. J Geriatr Psychiatry Neurol. 2001;14:37-41.
19. Gall A. Post stroke depression. Hosp Med. 2001;62:268-273.
20. Sekine Y, Iyo M, Tanaka K, Matsuyama K, Matsunaga T, Mori, N. Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: a case report. J Clin Psychopharmacol. 2000;20;584-585.
21. Cheer SM, Goa KL. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs. 2001;61:81-110.
22. Robinson RG. Treatment issues in poststroke depression. Depress Anxiety. 1998;8 (suppl 1):85-90.
23. Robinson, RG, Morris PL, Fedoroff JP. Depression and cerebrovascular disease. J Clin Psychiatry. 1990;51(suppl):26-31,32-33.
24. Fedoroff JP, Robinson RG. Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry. 1989;50(suppl):18-23,24-26.
25. Miyai I, Reding MJ. Antidepressant effect on recovery. In: L. Goldstein, ed. Restorative Neurology: Advances in Pharmacotherapy for Recovery After Stroke. New York: Futura Publishing; 1996.
26. Robinson RG, Lipsey JR, Price TR. Diagnosis and clinical management of post-stroke depression. Psychosomatics. 1985;26:769-772,775-778.
27. Goldstein LB. Pharmacology of recovery after stroke. Stroke. 1990;21:III139-III142.
28. Abreu dIT, Suarez-Monteagudo C, Araujo-Suarez F. [Depression in patients with neurological diseases. Proposed therapeutic strategies]. Rev Neurol. 2001;32:393-395.
29. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke. 2000;31:1482-1486.
30. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995;26:2254-2259.
31. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988;23:94-97.
32. Burns A. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry. 1999;14:681-685.
33. Palomaki H, Kaste M, Berg A, Lonnqvist R, Lonnqvist J, Lehtihalmes M, Hares J. Prevention of poststroke depression: 1 year randomized placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry. 1999;66:490-494.
34. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil. 1998;79:1047-1050.
35. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211-1214.
36. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099-1104.
37. Reding MJ, Orto LA, Winter SW, Fortuna IM, Di Ponte P, McDowell FH. Antidepressant therapy after stroke. A double-blind trial. Arch Neurol. 1986;43:763-765.
38. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet. 1984;1:297-300.
39. Miyai I, Reding MJ. Effects of antidepressants on functional recovery following stroke: a double-blind study. J Neuro Rehabil. 1998;12:5-13.
40. Lauritzen L, Bendsen BB, Vilmar T, Bendsen EB, Lunde M, Bech P. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology (Berl). 1994;114:119-122.
41. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351-359.
42. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829-1832.
43. Stamenkovic M, Schindler S, Kasper S. [Therapy of post-stroke depression with fluoxetine. A pilot project]. Nervenarzt. 1996;67:62-67.
44. Stamenkovic M, Schindler S, Kasper S. Poststroke depression and fluoxetine. Am J Psychiatry. 1996;153:446-447.
45. Lazarus LW, Winemiller DR, Lingam VR, et al. Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry. 1992;53:447-449.
46. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR. Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Phys Med Rehabil. 1994;75:403-406.
47. Balunov OA, Sadov OG, Alemasova AY. Therapy of depressions in post-stroke patients. Alaska Med. 1990;32:20-29.
48. Johnson ML, Roberts MD, Ross AR, Witten CM. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil. 1992;71:239-241.
49. Masand P, Murray GB, Pickett P. Psychostimulants in post-stroke depression. J Neuropsychiatry Clin Neurosci. 1991;3:23-27.
50. Finklestein SP, Weintraub RJ, Karmouz N, Askinazi C, Davar G, Baldessarini R. J. Antidepressant drug treatment for poststroke depression: retrospective study. Arch Phys Med Rehabil. 1987;68:772-776.
51. Shima S. The efficacy of antidepressants in post-stroke depression. Keio J Med. 1997;46:25-26.
52. Hougaku H, Matsumoto M, Hata R, et al. [Therapeutic effect of lisuride maleate on post-stroke depression]. Nippon Ronen Igakkai Zasshi. 1994;31:52-59.
53. Wiart L. [Post-cerebrovascular stroke depression]. Encephale. 1997;23(Spec No 3):51-54.
54. Erfurth A, Loew M, Wendler G, Floreanu A. [Depressive disorders in neurologic rehabilitation: therapy with paroxetine]. Psychiatr Prax. 2001;28:43-44.
55. Dahmen N, Marx J, Hopf HC, Tettenborn B, Roder R. Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke. 1999;30:691-692.
56. Lingam VR, Lazarus LW, Groves L, Oh SH. Methylphenidate in treating poststroke depression. J Clin Psychiatry. 1988;49:151-153.
57. Lauritzen L, Clemmesen L, Klysner R, et al. Combined treatment with imipramine and mianserin. A controlled pilot study. Pharmacopsychiatry. 1992;25:182-186.
58. Watzlawick P, Coyne JC. Depression following stroke: brief, problem-focused family treatment. Fam Process. 1980;19:13-18.
59. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil. 1997;11:114-122.
60. Hibbard MR, Grober SE, Gordon WA, Aletta EG, Freeman A. Cognitive therapy and the treatment of poststroke depression. Top Geriatr Rehabil. 1990;5:43-55.
61. Cameron, P. M. (1989). Psychodynamic psychotherapy for the depressive syndrome. Psychiatr J Univ Ott. 1989;14:397-402.
62. Currier MB, Murray GB, Welch CC. Electroconvulsive therapy for post-stroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci. 1992;4:140-144.
63. Weintraub D, Lippmann SB. Electroconvulsive therapy in the acute poststroke period. J ECT. 2000;16:415-418.
64. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry. 1986;47:258-260.
65. Pearlson GD, Robinson RG. Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res. 1981;218:233-242.
66. Robinson RG. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science. 1979;205:707-710.